FDA reverses stance on autism drug
The US Food and Drug Administration is no longer recommending a high-dose B vitamin medication (leucovorin) as a potential treatment for autism. Last fall, Health and Human Services Secretary Robert Kennedy Jr. claimed the drug could be a therapy for thousands of children with the condition.
March 11, 2026
China leaves lending benchmarks unchanged for 11th month in April
North Korea again tests cluster munitions in a launch observed by Kim and his daughter
Michigan refuses Trump administration demand for 2024 election ballots
US military strike on alleged drug boat kills 3 in Caribbean Sea
Hannah Green rallies to win the JM Eagle LA Championship for the 3rd time in 4 years
Asian airlines report Europe demand surge as Gulf hub disruption shifts traffic
Paolo Banchero scores 23 and Magic beat Pistons 112-101 to extend NBA's longest home postseason skid